Bonnefoy Luc 4

What Happened
Luc Bonnefoy, President, Surgical for Bausch & Lomb (BLCO), was reported as acquiring 10,202 common shares on Feb 18, 2026. The shares were recorded as an award/other acquisition at $0.00 (total reported value $0) and reflect performance stock units (PSUs) that met their performance conditions.

Key Details

• Transaction date: 2026-02-18; Filing date: 2026-02-20 (timely — within the usual 2-business-day Form 4 window).
• Reported acquisition: 10,202 shares at $0.00 per share (code A — award/grant).
• Shares owned after transaction: Not specified in this filing.
• Footnote: These are common shares underlying PSUs originally granted Mar 1, 2023 under the 2022 Omnibus Incentive Plan; the PSUs satisfied performance conditions on Feb 18, 2026 and the earned PSUs will vest on Mar 1, 2026, generally conditioned on continued employment.

Context
PSUs are performance-based equity awards. This filing reports that the performance conditions were met, converting the PSUs into shares to be vested March 1, 2026 (subject to employment). The $0 acquisition price reflects an earned award rather than a market purchase or sale — it is compensation, not a cash investment or divestment by the insider.